{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:18:14Z","timestamp":1787905094590,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the NU World Class: Food and Herb for Health and Beauty Project at the Naresuan University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"DOI":"10.1007\/s13318-026-01033-x","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:53:31Z","timestamp":1787903611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a Physiologically Based Pharmacokinetic\/Pharmacodynamic Model of Psilocybin\/Psilocin from Psilocybe cubensis (Magic Mushroom) in Treatment-Resistant Depression"],"prefix":"10.1007","author":[{"given":"Nilubon","family":"Thaoboonruang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Mei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornrat","family":"Lohitnavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimheang","family":"Ya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4439-0560","authenticated-orcid":false,"given":"Manupat","family":"Lohitnavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"1","key":"1033_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11682-019-00236-y","volume":"15","author":"L Luo","year":"2021","unstructured":"Luo L, Wu H, Xu J, Chen F, Wu F, Wang C, et al. Abnormal large-scale resting-state functional networks in drug-free major depressive disorder. Brain Imaging Behav. 2021;15(1):96\u2013106. https:\/\/doi.org\/10.1007\/s11682-019-00236-y.","journal-title":"Brain Imaging Behav"},{"issue":"6","key":"1033_CR2","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1037\/amp0000904","volume":"77","author":"American Psychological Association","year":"2022","unstructured":"American Psychological Association. Summary of the clinical practice guideline for the treatment of depression across three age cohorts. Am Psychol. 2022;77(6):770\u201380. https:\/\/doi.org\/10.1037\/amp0000904.","journal-title":"Am Psychol."},{"issue":"24","key":"1033_CR3","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1097\/cm9.0000000000002647","volume":"136","author":"Y Du","year":"2023","unstructured":"Du Y, Li Y, Zhao X, Yao Y, Wang B, Zhang L, et al. Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity. Chin Med J (Engl). 2023;136(24):2983\u201392. https:\/\/doi.org\/10.1097\/cm9.0000000000002647.","journal-title":"Chin Med J (Engl)"},{"key":"1033_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082081","author":"AS Correia","year":"2023","unstructured":"Correia AS, Cardoso A, Vale N. BDNF unveiled: exploring its role in major depression disorder serotonergic imbalance and associated stress conditions. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15082081.","journal-title":"Pharmaceutics"},{"issue":"16","key":"1033_CR5","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","volume":"109","author":"LX Shao","year":"2021","unstructured":"Shao LX, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, et al. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in\u00a0vivo. Neuron. 2021;109(16):2535\u201344. https:\/\/doi.org\/10.1016\/j.neuron.2021.06.008.","journal-title":"Neuron"},{"issue":"327","key":"1033_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jad.2023.01.108","volume":"14","author":"GMAS Goodwin","year":"2023","unstructured":"Goodwin GMAS, Alvarez O, Atli M, Bennett JC, Croal M, DeBattista C, et al. Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life. J Affect Disord. 2023;14(327):120\u20137.","journal-title":"J Affect Disord."},{"key":"1033_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101809","author":"R von Rotz","year":"2023","unstructured":"von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, et al. Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial. eClinicalMedicine. 2023. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101809.","journal-title":"eClinicalMedicine"},{"issue":"11","key":"1033_CR8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/0041-008X(62)90102-3","volume":"4","author":"AWL Horita","year":"1962","unstructured":"Horita AWL. Dephosphorylation of psilocybin in the intact mouse. Toxicol Appl Pharmacol. 1962;4(11):730\u20137.","journal-title":"Toxicol Appl Pharmacol."},{"issue":"7","key":"1033_CR9","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","volume":"44","author":"MK Madsen","year":"2019","unstructured":"Madsen MK, Fisher PM, Burmester D, Dyssegaard A, Stenb\u00e6k DS, Kristiansen S, et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology. 2019;44(7):1328\u201334. https:\/\/doi.org\/10.1038\/s41386-019-0324-9.","journal-title":"Neuropsychopharmacology"},{"key":"1033_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.euroneuro.2021.06.001","volume":"50","author":"MK Madsen","year":"2021","unstructured":"Madsen MK, Stenb\u00e6k DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, et al. Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience. Eur Neuropsychopharmacol. 2021;50:121\u201332. https:\/\/doi.org\/10.1016\/j.euroneuro.2021.06.001.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"1033_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","volume":"235","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl). 2018;235(2):399\u2013408. https:\/\/doi.org\/10.1007\/s00213-017-4771-x.","journal-title":"Psychopharmacology (Berl)"},{"issue":"18","key":"1033_CR12","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","volume":"387","author":"GM Goodwin","year":"2022","unstructured":"Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, et al. Single-dose psilocybin for a treatment-resistant episode of major depression. N Engl J Med. 2022;387(18):1637\u201348. https:\/\/doi.org\/10.1056\/NEJMoa2206443.","journal-title":"N Engl J Med"},{"issue":"12","key":"1033_CR13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol. 2016;30(12):1165\u201380. https:\/\/doi.org\/10.1177\/0269881116675512.","journal-title":"J Psychopharmacol"},{"issue":"12","key":"1033_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 2016;30(12):1181\u201397. https:\/\/doi.org\/10.1177\/0269881116675513.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"1033_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","volume":"29","author":"MP Bogenschutz","year":"2015","unstructured":"Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol. 2015;29(3):289\u201399. https:\/\/doi.org\/10.1177\/0269881114565144.","journal-title":"J Psychopharmacol"},{"issue":"11","key":"1033_CR16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0269881114548296","volume":"28","author":"MW Johnson","year":"2014","unstructured":"Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol. 2014;28(11):983\u201392. https:\/\/doi.org\/10.1177\/0269881114548296.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"1033_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.5960","volume":"7","author":"A Yerubandi","year":"2024","unstructured":"Yerubandi A, Thomas JE, Bhuiya N, Harrington C, Villa Zapata L, Caballero J. Acute adverse effects of therapeutic doses of psilocybin: a systematic review and meta-analysis. JAMA Netw Open. 2024;7(4):e245960. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.5960.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1033_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-98202-w","volume":"15","author":"N Thaoboonruang","year":"2025","unstructured":"Thaoboonruang N, Lohitnavy O, Ya K, Lohitnavy M. Development of a PBPK model of psilocybin\/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans. Sci Rep. 2025;15(1):13721. https:\/\/doi.org\/10.1038\/s41598-025-98202-w.","journal-title":"Sci Rep"},{"issue":"4","key":"1033_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, \u00c5sberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382\u20139. https:\/\/doi.org\/10.1192\/bjp.134.4.382.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"1033_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/02791072.2024.2399128","volume":"57","author":"N Thaoboonruang","year":"2025","unstructured":"Thaoboonruang N, Lohitnavy M, Lohitnavy O. Pharmacokinetics of psilocybin, a tryptamine alkaloid in magic mushroom (Psilocybe cubensis): a systematic review. J Psychoactive Drugs. 2025;57(4):386\u201398. https:\/\/doi.org\/10.1080\/02791072.2024.2399128.","journal-title":"J Psychoactive Drugs"},{"issue":"7","key":"1033_CR21","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1023\/A:1018943613122","volume":"10","author":"BMT Davies","year":"1993","unstructured":"Davies BMT. Physiological parameters in laboratory animals and humans. Pharm Res. 1993;10(7):1093\u20135.","journal-title":"Pharm Res."},{"issue":"4","key":"1033_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/074823379701300401","volume":"13","author":"R Brown","year":"1997","unstructured":"Brown R, Delp M, Lindstedt S, Rhomberg L, Beliles R. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health. 1997;13(4):407\u201384.","journal-title":"Toxicol Ind Health"},{"issue":"1","key":"1033_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/jps.10005","volume":"91","author":"P Poulin","year":"2002","unstructured":"Poulin P, Theil F. Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. J Pharm Sci. 2002;91(1):129\u201356. https:\/\/doi.org\/10.1002\/jps.10005.","journal-title":"J Pharm Sci"},{"issue":"3","key":"1033_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1124\/dmd.109.031138","volume":"38","author":"N Manevski","year":"2010","unstructured":"Manevski N, Kurkela M, H\u00f6glund C, Mauriala T, Court MH, Yli-Kauhaluoma J, et al. Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. Drug Metab Dispos. 2010;38(3):386\u201395. https:\/\/doi.org\/10.1124\/dmd.109.031138.","journal-title":"Drug Metab Dispos"},{"key":"1033_CR25","unstructured":"Madonna B. Berkeley Madonna. 10.3.2 ed. Berkeley, CA: University of California; 2023."},{"issue":"2","key":"1033_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/s0378-4347(98)00067-x","volume":"709","author":"H Lindenblatt","year":"1998","unstructured":"Lindenblatt H, Kr\u00e4mer E, Holzmann-Erens P, Gouzoulis-Mayfrank E, Kovar KA. Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction. J Chromatogr B Biomed Sci Appl. 1998;709(2):255\u201363. https:\/\/doi.org\/10.1016\/s0378-4347(98)00067-x.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"3","key":"1033_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0031-6865(97)00014-9","volume":"72","author":"F Hasler","year":"1997","unstructured":"Hasler F, Bourquin D, Brenneisen R, B\u00e4r T, Vollenweider FX. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharm Acta Helv. 1997;72(3):175\u201384. https:\/\/doi.org\/10.1016\/s0031-6865(97)00014-9.","journal-title":"Pharm Acta Helv"},{"issue":"1","key":"1033_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2013.71","volume":"3","author":"RN Upton","year":"2014","unstructured":"Upton RN, Mould DR. Basic concepts in population modeling, simulation, and model-based drug development: part 3-introduction to pharmacodynamic modeling methods. CPT Pharmacometrics Syst Pharmacol. 2014;3(1):e88. https:\/\/doi.org\/10.1038\/psp.2013.71.","journal-title":"CPT Pharmacometrics Syst Pharmacol."},{"issue":"6633","key":"1033_CR29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1126\/science.ade5278","volume":"379","author":"M Vargas","year":"2023","unstructured":"Vargas M, Dunlap L, Dong C, Carter S, Tombari R, Jami S, et al. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science. 2023;379(6633):700\u20136. https:\/\/doi.org\/10.1126\/science.ade5278.","journal-title":"Science."},{"key":"1033_CR30","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publishing; 2013.","edition":"5th ed"},{"issue":"1","key":"1033_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02039-0","volume":"12","author":"F Cavanna","year":"2022","unstructured":"Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L, et al. Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. Transl Psychiatry. 2022;12(1):307. https:\/\/doi.org\/10.1038\/s41398-022-02039-0.","journal-title":"Transl Psychiatry"},{"issue":"9","key":"1033_CR32","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1177\/02698811231182602","volume":"37","author":"C Pronovost-Morgan","year":"2023","unstructured":"Pronovost-Morgan C, Hartogsohn I, Ramaekers JG. Harnessing placebo: lessons from psychedelic science. J Psychopharmacol. 2023;37(9):866\u201375. https:\/\/doi.org\/10.1177\/02698811231182602.","journal-title":"J Psychopharmacol"},{"issue":"5","key":"1033_CR33","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1177\/1363461520983684","volume":"59","author":"N Gukasyan","year":"2022","unstructured":"Gukasyan N, Nayak SM. Psychedelics, placebo effects, and set and setting: insights from common factors theory of psychotherapy. Transcult Psychiatry. 2022;59(5):652\u201364. https:\/\/doi.org\/10.1177\/1363461520983684.","journal-title":"Transcult Psychiatry"},{"issue":"5","key":"1033_CR34","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00213-020-05464-5","volume":"237","author":"JA Olson","year":"2020","unstructured":"Olson JA, Suissa-Rocheleau L, Lifshitz M, Raz A, Veissi\u00e8re SPL. Tripping on nothing: placebo psychedelics and contextual factors. Psychopharmacology (Berl). 2020;237(5):1371\u201382. https:\/\/doi.org\/10.1007\/s00213-020-05464-5.","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"1033_CR35","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1038\/s41380-025-03233-4","volume":"30","author":"GE Chapman","year":"2025","unstructured":"Chapman GE, Turner G, Noar AP, Barba T, Zafar R, McCutcheon RA, et al. Cortical 5-HT(2A) receptors in depression and suicide: a systematic review and meta-analysis of in vivo and post-mortem imaging studies. Mol Psychiatry. 2025;30(12):6045\u201362. https:\/\/doi.org\/10.1038\/s41380-025-03233-4.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1033_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/cpdd.796","volume":"10","author":"EHP Dahmane","year":"2021","unstructured":"Dahmane EHP, Gobburu JVS. Exposure-response analysis to assess the concentration-QTc relationship of psilocybin\/psilocin. Clin Pharmacol Drug Dev. 2021;10(1):78\u201385.","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"4","key":"1033_CR37","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/0269881120959609","volume":"35","author":"DS Stenb\u00e6k","year":"2021","unstructured":"Stenb\u00e6k DS, Madsen MK, Ozenne B, Kristiansen S, Burmester D, Erritzoe D, et al. Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans. J Psychopharmacol. 2021;35(4):459\u201368. https:\/\/doi.org\/10.1177\/0269881120959609.","journal-title":"J Psychopharmacol"},{"key":"1033_CR38","doi-asserted-by":"publisher","DOI":"10.1017\/s1092852922000888","author":"S Dodd","year":"2022","unstructured":"Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, et al. Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy. CNS Spectr. 2022. https:\/\/doi.org\/10.1017\/s1092852922000888.","journal-title":"CNS Spectr."},{"key":"1033_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126713","author":"A Wojtas","year":"2022","unstructured":"Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Ma\u015blanka I, Herian M, et al. Effect of psilocybin and ketamine on brain neurotransmitters, glutamate receptors, DNA and rat behavior. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23126713.","journal-title":"Int J Mol Sci"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-026-01033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-026-01033-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-026-01033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:53:32Z","timestamp":1787903612000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-026-01033-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":39,"alternative-id":["1033"],"URL":"https:\/\/doi.org\/10.1007\/s13318-026-01033-x","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest related to this work.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve new human or animal experiments.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve the recruitment of human participants or the collection of new clinical data. All data used were obtained from previously published studies.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The manuscript does not contain any personal data in any form.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}